2,814
Views
3
CrossRef citations to date
0
Altmetric
Oncology

The cost-effectiveness of glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed acute myeloid leukemia in adult patients who are not eligible to receive intensive induction chemotherapy in Canada

, , , ORCID Icon &
Pages 150-161 | Received 23 Oct 2020, Accepted 21 Dec 2020, Published online: 01 Feb 2021